From what 1 stock analysts predict, the share price for Simulations Plus Inc (SLP) might increase by 68.69% in the next year. This is based on a 12-month average estimation for SLP. Price targets go from $47 to $65. The majority of stock analysts believe SLP is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
About 1 Wall Street analysts have assigned SLP 1 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Simulations Plus Inc to outperform the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on SLP. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of SLP.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Scott Schoenhaus Keybanc | Overweight | $47 | Initiates | Jul 29, 2024 |
Constantine Davides JMP Securities | Market Perform | Initiates | Jul 16, 2024 | |
Matt Hewitt Craig-Hallum | Buy | $56 | Reiterates | Jul 3, 2024 |
Max Smock William Blair | Outperform | Initiates | Jun 28, 2024 | |
Francois Brisebois Oppenheimer | Outperform | $65 | Maintains | Jun 13, 2024 |
Matt Hewitt Craig-Hallum | Buy | $56 | Maintains | Jun 13, 2024 |
Matt Hewitt Craig-Hallum | Buy | $51 | Maintains | Jan 4, 2024 |
Francois Brisebois Oppenheimer | Outperform | $67 | Reiterates | Jul 7, 2023 |
Oppenheimer | Outperform | Maintains | Jun 21, 2023 | |
David Larsen BTIG | Buy | $55 | Initiates | May 9, 2023 |
Francois Brisebois Oppenheimer | Outperform | $65 | Reiterates | Apr 6, 2023 |
Dane Leone Raymond James | Outperform | $70 | Maintains | Aug 29, 2022 |
Matt Hewitt Craig-Hallum | Buy | $60 | Maintains | Jul 7, 2022 |
Matt Hewitt Craig-Hallum | Buy | $53 | Upgrade | Oct 26, 2021 |
Dane Leone Raymond James | Outperform | $54 | Maintains | Jul 13, 2021 |
Craig-Hallum | Hold | Downgrade | Jan 12, 2021 | |
Raymond James | Outperform | Initiates | Oct 16, 2020 | |
Oppenheimer | Outperform | Initiates | Sep 8, 2020 | |
Craig-Hallum | Buy | Initiates | Jan 6, 2020 | |
Sidoti & Co. | Initiates | Mar 12, 2013 |
When did it IPO
N/A
Staff Count
192
Country
United States
Sector/Industry
Healthcare/Health Information Services
CEO
Market Cap
$732.5M
In 2023, SLP generated $59.6M in revenue, which was a increase of 10.52% from the previous year. This can be seen as a signal that SLP's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
No news data available.